Cytodyn Inc (CYDY)

[woodenbear]

Several people here have already summed up my thoughts after today’s call very well. I was frustrated with NP and have communicated those to the company and Paulson already. He is not the guy to bring this home. Obviously, all parties involved are relieved that the new Business Development position will allow someone else to handle the outreach and sales for the company.

The only perspective I’ll add are 2 critical facts that we know at this point.

1. Mono works with 90% responders rate.
2. They have funding (dilutive or non dilutive) to get to market. Paulson is so bought in at this point given prior 16 rounds and $150mm raised to back out. They can’t walk away with the science remaining so strong.

Dilutive or non dilutive doesn’t really matter to me at this point. The two facts above mean we all make serious money. Hopefully, a deal strikes soon and the need for Paulson is limited. I take the fact that the shelf offering was voluntarily closed last week as a sign of confidence.

Cancer is just a really plausible cherry on top at this point. But doesn’t change or really even factor into my investment strategy. All that’s left is the how much and when question.